Virbac SA (EPA:VIRP)
France · Delayed Price · Currency is EUR 352.00
-2.50 (-0.71%)
At close: Mar 20, 2026
Virbac Market Cap
Virbac has a market cap or net worth of €2.95 billion as of March 20, 2026. Its market cap has increased by 15.64% in one year.
Market Cap
2.95B
Enterprise Value
3.11B
Revenue
1.46B
Ranking
n/a
PE Ratio
19.54
Stock Price
€352.00
Market Cap Chart
Since August 8, 1994, Virbac's market cap has increased from 217.52M to 2.95B, an increase of 1,255.74%. That is a compound annual growth rate of 8.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 2.95B | -1.54% |
| Dec 31, 2025 | 3.00B | 13.00% |
| Dec 31, 2024 | 2.65B | -12.68% |
| Dec 29, 2023 | 3.04B | 57.52% |
| Dec 30, 2022 | 1.93B | -46.24% |
| Dec 31, 2021 | 3.58B | 78.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 94.37B |
| EssilorLuxottica Société anonyme | 91.71B |
| Sartorius Stedim Biotech | 16.67B |
| Ipsen | 12.50B |
| ABIVAX Société Anonyme | 8.25B |
| emeis Société anonyme | 2.21B |
| Nanobiotix | 1.33B |
| Clariane SE | 1.32B |